799 related articles for article (PubMed ID: 19786631)
1. Cardiomyocyte differentiation of human induced pluripotent stem cells.
Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
[TBL] [Abstract][Full Text] [Related]
2. Scalable production of cardiomyocytes derived from c-Myc free induced pluripotent stem cells.
Zwi-Dantsis L; Mizrahi I; Arbel G; Gepstein A; Gepstein L
Tissue Eng Part A; 2011 Apr; 17(7-8):1027-37. PubMed ID: 21087204
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
[TBL] [Abstract][Full Text] [Related]
4. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart.
Sequiera GL; Mehta A; Ooi TH; Shim W
Life Sci; 2013 Jan; 92(1):63-71. PubMed ID: 23142239
[TBL] [Abstract][Full Text] [Related]
5. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
[TBL] [Abstract][Full Text] [Related]
6. Novel cell lines derived from adult human ventricular cardiomyocytes.
Davidson MM; Nesti C; Palenzuela L; Walker WF; Hernandez E; Protas L; Hirano M; Isaac ND
J Mol Cell Cardiol; 2005 Jul; 39(1):133-47. PubMed ID: 15913645
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic stem cells for cardiomyogenesis.
Habib M; Caspi O; Gepstein L
J Mol Cell Cardiol; 2008 Oct; 45(4):462-74. PubMed ID: 18775434
[TBL] [Abstract][Full Text] [Related]
9. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
Narazaki G; Uosaki H; Teranishi M; Okita K; Kim B; Matsuoka S; Yamanaka S; Yamashita JK
Circulation; 2008 Jul; 118(5):498-506. PubMed ID: 18625891
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
[TBL] [Abstract][Full Text] [Related]
11. Time-dependence of cardiomyocyte differentiation disturbed by peroxisome proliferator-activated receptor alpha inhibitor GW6471 in murine embryonic stem cells in vitro.
Ding L; Liang XG; Lou YJ
Acta Pharmacol Sin; 2007 May; 28(5):634-42. PubMed ID: 17439719
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells.
Mummery C; Ward-van Oostwaard D; Doevendans P; Spijker R; van den Brink S; Hassink R; van der Heyden M; Opthof T; Pera M; de la Riviere AB; Passier R; Tertoolen L
Circulation; 2003 Jun; 107(21):2733-40. PubMed ID: 12742992
[TBL] [Abstract][Full Text] [Related]
13. Differentiation pathways in human embryonic stem cell-derived cardiomyocytes.
Lev S; Kehat I; Gepstein L
Ann N Y Acad Sci; 2005 Jun; 1047():50-65. PubMed ID: 16093484
[TBL] [Abstract][Full Text] [Related]
14. Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells.
Hatami L; Valojerdi MR; Mowla SJ
Int J Cardiol; 2007 Apr; 117(1):80-9. PubMed ID: 17034884
[TBL] [Abstract][Full Text] [Related]
15. Use of long-term cultured embryoid bodies may enhance cardiomyocyte differentiation by BMP2.
Kim YY; Ku SY; Jang J; Oh SK; Kim HS; Kim SH; Choi YM; Moon SY
Yonsei Med J; 2008 Oct; 49(5):819-27. PubMed ID: 18972603
[TBL] [Abstract][Full Text] [Related]
16. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of functional cardiomyocytes from rhesus monkey embryonic stem cells.
Schwanke K; Wunderlich S; Reppel M; Winkler ME; Matzkies M; Groos S; Itskovitz-Eldor J; Simon AR; Hescheler J; Haverich A; Martin U
Stem Cells; 2006 Jun; 24(6):1423-32. PubMed ID: 16543489
[TBL] [Abstract][Full Text] [Related]
18. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
Freund C; Mummery CL
J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
[TBL] [Abstract][Full Text] [Related]
19. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.
Niebruegge S; Bauwens CL; Peerani R; Thavandiran N; Masse S; Sevaptisidis E; Nanthakumar K; Woodhouse K; Husain M; Kumacheva E; Zandstra PW
Biotechnol Bioeng; 2009 Feb; 102(2):493-507. PubMed ID: 18767184
[TBL] [Abstract][Full Text] [Related]
20. Functional consequences of overexpressing the gap junction Cx43 in the cardiogenic potential of pluripotent human embryonic stem cells.
Moore JC; Tsang SY; Rushing SN; Lin D; Tse HF; Chan CW; Li RA
Biochem Biophys Res Commun; 2008 Dec; 377(1):46-51. PubMed ID: 18823947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
